Vanda Pharmaceuticals Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
VNDA on Nasdaq
Location
Washington, DC
Fiscal year end
31 December
Latest financial report
12 Feb 2026

Quick Takeaways

  • VNDA - Vanda Pharmaceuticals Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity -51%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+1360%</span>.
  • Most recent SEC facts end date: 05 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-05) highlights Return On Equity -50.9%, Return On Assets -16.5%, and Operating Margin -70.5%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

39.7/100

Weak Confidence high

Return On Equity

-51%

Metric score 0.0/100

Return On Assets

-17%

Metric score 0.0/100

Financial Health

Current Ratio
2.39x
Quick Ratio
2.19x
Debt to Equity
0.04x

Strengths

Current Ratio and Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-51%

YoY: +1360%

Industry median: -43% (n=675)

View history

Return On Assets

-17%

YoY: +1229%

Industry median: -47% (n=673)

View history

Operating Margin

-71%

YoY: +242%

Industry median: -121% (n=298)

View history

Current Ratio

2.39x

YoY: -46%

Industry median: 3.39x (n=667)

View history

Quick Ratio

2.19x

YoY: -36%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

0.04x

YoY: +53%

Industry median: 0.26x (n=530)

View history

Revenues YoY

8.7%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

-1067%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -51% +1360%
Return On Assets -16% +1229%
Operating Margin -71% +242%

Financial Health

Metric Latest value YoY change
Current Ratio 2.39x -46%
Quick Ratio 2.19x -36%
Debt-to-equity 0.04x +53%

Growth

Metric Latest value YoY change
Revenues YoY 8.7%
NetIncomeLoss YoY -1067%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 59,108,030 +1.4%
Common Stock, Shares, Outstanding 59,101,630 +1.4%
Common Stock, Value, Issued $59,000 +1.7%
Weighted Average Number of Shares Outstanding, Basic 58,930,157 +1.3%
Weighted Average Number of Shares Outstanding, Diluted 58,930,157 +1.3%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $216,105,000 +8.7%
Research and Development Expense $109,271,000 +47%
Costs and Expenses $367,273,000 +53%
Operating Income (Loss) $151,168,000 -272%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $138,647,000 -505%
Income Tax Expense (Benefit) $81,827,000
Earnings Per Share, Basic -3.74 -1033%
Earnings Per Share, Diluted -3.74 -1033%
Cash and Cash Equivalents, at Carrying Value $84,851,000 -17%
Accounts Receivable, after Allowance for Credit Loss, Current $54,578,000 +16%
Inventory, Net $1,852,000 +7.3%
Assets, Current $347,262,000 -21%
Deferred Income Tax Assets, Net $0 -100%
Property, Plant and Equipment, Net $2,248,000 +5.4%
Operating Lease, Right-of-Use Asset $3,923,000 -30%
Assets $488,948,000 -25%
Employee-related Liabilities, Current $10,322,000 +22%
Liabilities, Current $145,162,000 +45%
Operating Lease, Liability, Noncurrent $2,991,000 -40%
Other Liabilities, Noncurrent $9,533,000 -0.56%
Liabilities $161,762,000 +37%
Accumulated Other Comprehensive Income (Loss), Net of Tax $629,000 +750%
Retained Earnings (Accumulated Deficit) $394,766,000 -126%
Stockholders' Equity Attributable to Parent $327,186,000 -39%
Liabilities and Equity $488,948,000 -25%
Common Stock, Shares Authorized 150,000,000 0%
Common Stock, Shares, Issued 59,101,630 +1.4%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85,320,000 -17%
Deferred Tax Assets, Valuation Allowance $124,401,000 +1300%
Deferred Tax Assets, Gross $127,254,000 +38%
Operating Lease, Liability $5,143,000 -30%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $219,919,000 -1070%
Lessee, Operating Lease, Liability, to be Paid $5,670,000 -33%
Property, Plant and Equipment, Gross $14,864,000 +8.5%
Operating Lease, Liability, Current $2,152,000 -12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,159,000 -10%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,412,000 -14%
Operating Lease, Weighted Average Discount Rate, Percent 0.082 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $527,000 -50%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,099,000 -49%
Deferred Tax Assets, Operating Loss Carryforwards $22,000,000 +269%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 20,000,000 0%
Unrecognized Tax Benefits $19,575,000 +4.1%
Preferred Stock, Shares Outstanding 0
Amortization of Intangible Assets $7,007,000 -3.7%
Deferred Tax Assets, Net of Valuation Allowance $0 -100%
Share-based Payment Arrangement, Expense $9,474,000 -24%
Preferred Stock, Par or Stated Value Per Share 0.001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY